COLLECTING DUCT CARCINOMA
Clinical trials for COLLECTING DUCT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLLECTING DUCT CARCINOMA trials appear
Sign up with your email to follow new studies for COLLECTING DUCT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug attack shows promise for rare bladder and kidney cancers
Disease control Recruiting nowThis study tests a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—in people with rare genitourinary cancers that have spread. The goal is to see if this mix can shrink tumors or stop them from growing. About 314 adults with these rare cancers will take part. T…
Matched conditions: COLLECTING DUCT CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
New drug combo targets rare, tough kidney cancers
Disease control Recruiting nowThis study tests a combination of two drugs, pembrolizumab and enfortumab vedotin, for people with rare and aggressive kidney cancers (collecting duct carcinoma and renal medullary carcinoma). About 23 adults with advanced or metastatic disease will receive the treatment for seve…
Matched conditions: COLLECTING DUCT CARCINOMA
Phase: PHASE2 • Sponsor: Giuseppe Procopio • Aim: Disease control
Last updated May 06, 2026 16:03 UTC